Template:COVID-19 Testing, Reporting, and Information Management in the Laboratory/Final thoughts and additional resources/Key guidance documents

5.2 Key guidance documents

• Centers for Disease Control and Prevention (16 September 2021). "Contact Tracing". Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/php/contact-tracing/index.html. 

• Centers for Disease Control and Prevention (8 July 2021). "Guidance for SARS-CoV-2 Point-of-Care and Rapid Testing". Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/lab/point-of-care-testing.html. 

• Centers for Disease Control and Prevention (26 January 2021). "How to Report COVID-19 Laboratory Data". Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/lab/reporting-lab-data.html. 

• Centers for Disease Control and Prevention (30 June 2021). "Interim Guidance for Use of Pooling Procedures in SARS-CoV-2 Diagnostic and Screening Testing". Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/lab/pooling-procedures.html. 

• Centers for Disease Control and Prevention (26 February 2021). "Interim Guidelines for Collecting and Handling of Clinical Specimens for COVID-19 Testing". Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-nCoV/lab/guidelines-clinical-specimens.html. 

• Centers for Disease Control and Prevention (11 June 2021). "Interim Laboratory Biosafety Guidelines for Handling and Processing Specimens Associated with Coronavirus Disease 2019 (COVID-19)". Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-nCoV/lab/lab-biosafety-guidelines.html. 

• Centers for Disease Control and Prevention (2 August 2021). "Overview of Testing for SARS-CoV-2 (COVID-19)". Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/hcp/testing-overview.html. 

• Centers for Disease Control and Prevention (13 August 2021). "Testing Strategies for SARS-CoV-2". Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/sars-cov2-testing-strategies.html. 

• Centers for Medicare & Medicaid Services (August 2021). "ICD-10-CM Official Guidelines for Coding and Reporting - FY 2022" (PDF). Centers for Medicare & Medicaid Services. https://www.cms.gov/files/document/fy-2022-icd-10-cm-coding-guidelines.pdf. 

• European Commission (19 October 2020). "Coronavirus: EU interoperability gateway for contact tracing and warning apps – Questions and Answers". European Union. https://ec.europa.eu/commission/presscorner/detail/en/QANDA_20_1905. 

• European Data Protection Board (21 April 2020). "Guidelines 04/2020 on the use of location data and contact tracing tools in the context of the COVID-19 outbreak" (PDF). European Union. https://edpb.europa.eu/sites/default/files/files/file1/edpb_guidelines_20200420_contact_tracing_covid_with_annex_en.pdf. 

• Occupational Safety and Health Administration (13 August 2021). "Protecting Workers: Guidance on Mitigating and Preventing the Spread of COVID-19 in the Workplace". Occupational Safety and Health Administration. https://www.osha.gov/coronavirus/safework. 

• Pan American Health Organization (8 July 2020). "Laboratory Guidelines for the Detection and Diagnosis of COVID-19 Virus Infection". Pan American Health Organization. https://iris.paho.org/handle/10665.2/52458. 

• Public Health England (29 March 2021). "COVID-19: Guidance for sampling and for diagnostic laboratories". U.K Government. https://www.gov.uk/government/publications/wuhan-novel-coronavirus-guidance-for-clinical-diagnostic-laboratories. 

• Public Health Laboratory Network (22 June 2021). "PHLN guidance on laboratory testing for SARS-CoV-2 (the virus that causes COVID-19)". Department of Health, Australian Government. https://www.health.gov.au/resources/publications/phln-guidance-on-laboratory-testing-for-sars-cov-2-the-virus-that-causes-covid-19. 

• U.S. Food and Drug Administration (September 2021). "Enforcement Policy for Face Masks, Barrier Face Coverings, Face Shields, Surgical Masks, and Respirators During the Coronavirus Disease (COVID-19) Public Health Emergency (Revised)". FDA-2020-D-1138. U.S. Food and Drug Administration. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/enforcement-policy-face-masks-barrier-face-coverings-face-shields-surgical-masks-and-respirators. 

• U.S. Food and Drug Administration (30 March 2020). "Enforcement Policy for Gowns, Other Apparel, and Gloves During the Coronavirus Disease (COVID-19) Public Health Emergency". FDA-2020-D-1138-0023. U.S. Food and Drug Administration. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/enforcement-policy-gowns-other-apparel-and-gloves-during-coronavirus-disease-covid-19-public-health. 

• U.S. Food and Drug Administration (15 May 2020). "Policy for Coronavirus Disease-2019 Tests During the Public Health Emergency (Revised)". FDA-2020-D-0987-0049. U.S. Food and Drug Administration. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/policy-coronavirus-disease-2019-tests-during-public-health-emergency-revised. 

• World Health Organization, et al. (2 October 2020). "Assessment tool for laboratories implementing SARS-CoV-2 testing: Interim guidance, 2 October 2020". WHO/2019-nCoV/Lab_Assessment_Tool/2020.2. World Health Organization. https://apps.who.int/iris/handle/10665/335843. 

• World Health Organization, et al. (11 September 2020). "Diagnostic testing for SARS-CoV-2: Interim guidance, 11 September 2020". WHO/2019-nCoV/laboratory/2020.6. World Health Organization. https://apps.who.int/iris/handle/10665/334254. 

• World Health Organization, et al. (13 May 2020). "Laboratory biosafety guidance related to coronavirus disease (COVID-19): Interim guidance, 13 May 2020". WHO/WPE/GIH/2020.3. World Health Organization. https://apps.who.int/iris/handle/10665/332076.